PortfoliosLab logoPortfoliosLab logo
LU vs. PFE
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Performance

LU vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lufax Holding Ltd (LU) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

LU vs. PFE - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
LU
Lufax Holding Ltd
-26.95%7.11%-22.15%-58.03%-60.48%-60.35%10.51%
PFE
Pfizer Inc.
14.66%0.65%-2.22%-41.26%-10.41%66.70%10.48%

Fundamentals

Total Revenue (TTM)

LU:

$31.92B

PFE:

$62.58B

Gross Profit (TTM)

LU:

$13.50B

PFE:

$44.01B

EBITDA (TTM)

LU:

-$1.26B

PFE:

$15.10B

Returns By Period

In the year-to-date period, LU achieves a -26.95% return, which is significantly lower than PFE's 14.66% return.


LU

1D
5.06%
1M
-28.08%
YTD
-26.95%
6M
-53.94%
1Y
-37.04%
3Y*
-37.59%
5Y*
-47.72%
10Y*

PFE

1D
1.12%
1M
1.56%
YTD
14.66%
6M
14.02%
1Y
18.86%
3Y*
-6.22%
5Y*
-0.14%
10Y*
4.32%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LU vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LU
LU Risk / Return Rank: 1616
Overall Rank
LU Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
LU Sortino Ratio Rank: 1414
Sortino Ratio Rank
LU Omega Ratio Rank: 1616
Omega Ratio Rank
LU Calmar Ratio Rank: 2121
Calmar Ratio Rank
LU Martin Ratio Rank: 1616
Martin Ratio Rank

PFE
PFE Risk / Return Rank: 6565
Overall Rank
PFE Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
PFE Sortino Ratio Rank: 6161
Sortino Ratio Rank
PFE Omega Ratio Rank: 5959
Omega Ratio Rank
PFE Calmar Ratio Rank: 6969
Calmar Ratio Rank
PFE Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LU vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lufax Holding Ltd (LU) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LUPFEDifference

Sharpe ratio

Return per unit of total volatility

-0.66

0.71

-1.37

Sortino ratio

Return per unit of downside risk

-0.80

1.17

-1.97

Omega ratio

Gain probability vs. loss probability

0.91

1.15

-0.24

Calmar ratio

Return relative to maximum drawdown

-0.62

1.32

-1.93

Martin ratio

Return relative to average drawdown

-1.28

3.18

-4.46

LU vs. PFE - Sharpe Ratio Comparison

The current LU Sharpe Ratio is -0.66, which is lower than the PFE Sharpe Ratio of 0.71. The chart below compares the historical Sharpe Ratios of LU and PFE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


LUPFEDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.66

0.71

-1.37

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.60

-0.01

-0.59

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.18

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.55

0.26

-0.81

Correlation

The correlation between LU and PFE is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

LU vs. PFE - Dividend Comparison

LU has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.13%.


TTM20252024202320222021202020192018201720162015
LU
Lufax Holding Ltd
0.00%0.00%0.00%11.60%26.29%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PFE
Pfizer Inc.
6.13%6.91%6.33%5.70%3.12%2.64%3.92%3.68%3.12%3.53%3.69%3.47%

Drawdowns

LU vs. PFE - Drawdown Comparison

The maximum LU drawdown since its inception was -97.25%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for LU and PFE.


Loading graphics...

Drawdown Indicators


LUPFEDifference

Max Drawdown

Largest peak-to-trough decline

-97.25%

-58.96%

-38.29%

Max Drawdown (1Y)

Largest decline over 1 year

-59.55%

-12.59%

-46.96%

Max Drawdown (5Y)

Largest decline over 5 years

-96.32%

-58.96%

-37.36%

Max Drawdown (10Y)

Largest decline over 10 years

-58.96%

Current Drawdown

Current decline from peak

-97.12%

-42.75%

-54.37%

Average Drawdown

Average peak-to-trough decline

-79.63%

-17.33%

-62.30%

Ulcer Index

Depth and duration of drawdowns from previous peaks

28.68%

6.13%

+22.55%

Volatility

LU vs. PFE - Volatility Comparison

Lufax Holding Ltd (LU) has a higher volatility of 15.15% compared to Pfizer Inc. (PFE) at 6.75%. This indicates that LU's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


LUPFEDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.15%

6.75%

+8.40%

Volatility (6M)

Calculated over the trailing 6-month period

39.88%

18.50%

+21.38%

Volatility (1Y)

Calculated over the trailing 1-year period

56.42%

26.73%

+29.69%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

80.32%

25.46%

+54.86%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

80.49%

23.90%

+56.59%

Financials

LU vs. PFE - Financials Comparison

This section allows you to compare key financial metrics between Lufax Holding Ltd and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


5.00B10.00B15.00B20.00B25.00BAprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober
4.45B
17.56B
(LU) Total Revenue
(PFE) Total Revenue
Values in USD except per share items